Cited by 227Berberine and alkaloids researchPlant-based Medicinal ResearchPlant Toxicity and Pharmacological Properties

Toxicological Effects of Berberine and Sanguinarine

Open access
Singh, Nitika, Sharma, Bechan·2018·Frontiers in Molecular Biosciences

Abstract

Berberine and Sanguinarine alkaloids belong to a group of naturally occurring chemical compounds that mostly contain basic nitrogen atoms. This group also includes some related compounds with neutral or weakly acidic properties. Alkaloids are produced by a large number of organisms including bacteria, fungi, plants, and animals. Berberine and Sanguinarine both are isoquinoline derivatives and belong to protoberberine and benzophenanthridines, respectively. Tyrosine or phenylalanine is common precursor for the biosynthesis of both. Sanguinarine [13-methyl (1,3) benzodioxolo(5,6-c)-1,3-dioxolo (4,5) phenanthridinium] is a toxin that kills animal cells through its action on the Na+-K+-ATPase transmembrane protein. Berberine, on the other hand, has been reported to cause cytotoxicity and adversely influence the synthesis of DNA. Several workers have reported varied pharmacological properties of these alkaloids as they exhibit antibacterial, antiasthma, anticancer, anti-inflammatory, and antidiabetic activities. This review article illustrates the toxicological effects of berberine and sanguinarine as well as mechanistic part of berberine and sanguinarine mediated toxicity in different living systems. This manuscript has included the lethal doses (LD50) of berberine and sanguinarine in different animals via different routs of exposure. Also, the effects of these alkaloids on the activities of some key enzymes, cell lines and organ development etc. have been summarized.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmolb.2018.00021

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The heterogeneity of commercial products limits the generalizability of any effect-size estimate.

    “Finally, the heterogeneity of commercial products limits the generalizability of any effect-size estimate [32,33].”

    From Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review (2026) · cites this paper as [33]

    The 'Toxicological effects of berberine' section (page unavailable) says LD50 varies with the amount of berberine in a compound, route of administration, and organism, and compares values for extracts and pure berberine. It does not discuss heterogeneity among commercial products or conclude that such heterogeneity limits the generalizability of any effect-size estimate. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • The toxicity of berberine and related alkaloids depends on dose and formulation.

    “The toxicity of berberine and related alkaloids also depends on dose and formulation [33,111]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Manske R. H. F. Holmes H. L. (1995). The Alkaliods: Chemistry and Physiology. New York, NY: Academic Press.

Cited by

Sorted by citations

Authors
Singh, N., & Sharma, B.
Affiliations
University of Allahabad (IN)
Corresponding author
Sharma, Bechan
Venue
Frontiers in Molecular Biosciences
Published
2018-03-19
Volume
5
Pages
21-21
ISSN
2296-889X (ISSN-L)
OpenAlex
W2790121275
Cited by
227
References
54
Citations by year
2026: 19 · 2025: 32 · 2024: 31 · 2023: 35 · 2022: 40 · 2021: 31 · 2020: 28 · 2019: 8 · 2018: 3
FWCI
2.04
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Molecular Biosciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University Grants Commission
Topics
  • Health Sciences › Medicine › Pharmacology › Berberine and alkaloids research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Plant-based Medicinal Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant Toxicity and Pharmacological Properties
Keywords
berberine, sanguinarine, isoquinoline alkaloids, protoberberine alkaloids, benzophenanthridine alkaloids, alkaloid toxicity, Na+/K+-ATPase inhibition, cytotoxicity, DNA synthesis inhibition, lethal dose, pharmacological activity, organogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review